chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Narrative:  77 yo M, received dose #1 of the Moderna COVID-19 vaccine on 3/4/2021 (Lot#: 011A21A; Exp Date: 08/16/2021) around 10:00. Inpatient information documented in medical record that patient experienced dizziness and slight elevation in temperature (100.9) possibly attributable to COVID-19 vaccination. Symptoms appeared the day after vaccination. Reaction classified as mild as no intervention required. Of note, no reaction documented to dose #2 administered 4/3/2021 (Lot#019B21A; Exp Date: 09/21/2021).
Very very severe pain in arm where vaccine was injected.  I can barely move my arm- feels like there a golf ball stuck in my arm and the pain is shooting down to my fingers!  It's really unbareable
flu like symptoms; This case was reported by a consumer via call center representative and described the occurrence of influenza-like symptoms in a 62-year-old male patient who received Herpes zoster (Shingrix) (batch number 4257F, expiry date 11th September 2021) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of influenza like illness (1st dose received on 18th February 2019, for tolerance refer case US2019AMR149954).   On 7th May 2019, the patient received the 2nd dose of Shingrix. On an unknown date, less than 4 months after receiving Shingrix, the patient experienced influenza-like symptoms. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the influenza-like symptoms was unknown.   It was unknown if the reporter considered the influenza-like symptoms to be related to Shingrix.  Additional details were provided as follows: The patient had flu-like symptoms after receiving 2nd shot of Shingrix. The patient consented to follow up and provided contact details of his physician. No additional details were available as the patient's cell phone was disconnected in a remote location. This case is linked with US2019149405, reported by the patient for his wife.
Arm on fire burning, fever dizziness nausea tired fever chills sweats pains in muscles bones lymph nodes swollen are dry throat yellow tongue could not urinate then urgency brown urine.  Fever started night of shot and still have yellow tongue, sore dry throat swollen lymph nodes, some dizziness and small amount nausea
started having fever and chills and went through that on Sunday and now she is having cold symptoms/tested positive for Covid; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team, Program ID. The reporter is the patient.  A 54-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 28Oct2022 as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; COVID-19 vaccine (COVID-19 VACCINE), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: COVID-19 (non-serious) with onset Oct2022, outcome "unknown", described as "started having fever and chills and went through that on Sunday and now she is having cold symptoms/tested positive for Covid". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (01Nov2022) Positive, notes: She tested positive for Covid today. Clinical course: The patient had her booster shot last Friday (28Oct2022) and she just tested positive this morning (01Nov2022). She started having fever and chills and went through that on Sunday (in Oct2022) and now she is having cold symptoms. The patient asked if this could be the result of the booster or was it just a coincidence that she has Covid.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Case number PHHY2011US65892 is an incomplete spontaneous report received from a nurse on 20 Jul 2011. This report refers to a group of patients. There were given only less than 0.5 ml dose of MENVEO (batch number: unknown) intramuscularly on unknown dates due to difficulty in withdrawing full dose after reconstitution. No other adverse reaction was reported.
Pt stated she recieved the vaccine on the 30th of AUG 2022.  The next day 31 AUG 2022 she stated she was experincing bumpls that look like a rash on her neck and chest area with severe back pain , that radiated to her stomach and chills. Pt. stated the pain lasted about a day or so and has subsided along with the rash and chills.  Pt. stated she is currently experiencing very mild chills every now and then (according to the pt.)  Pt stated she does not take her prescibed medicatoions as directed because she stated feels better when she doesnt take them. Pt. has an appointment on 29 SEPT 2022 for dose #2.  The Pt. was told that a member from health department will reach out to her with further instructions in regards to her case.
pain has been going on for about three months now; pain in different areas of her body including her knee, ankles, shoulders, and arms; pain in different areas of her body including her knee, ankles, shoulders, and arms; pain in different areas of her body including her knee, ankles, shoulders, and arms; pain in different areas of her body including her knee, ankles, shoulders, and arms; history of pain in those area prior to the vaccine but after the vaccine, her pain is more frequent; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in different areas of her body including her knee, ankles, shoulders, and arms), PAIN (history of pain in those area prior to the vaccine but after the vaccine, her pain is more frequent), PAIN (pain has been going on for about three months now), the first episode of ARTHRALGIA (pain in different areas of her body including her knee, ankles, shoulders, and arms) and the second episode of ARTHRALGIA (pain in different areas of her body including her knee, ankles, shoulders, and arms) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included GABAPENTIN and DICLOFENAC for an unknown indication.   On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Feb-2021, the patient experienced PAIN (history of pain in those area prior to the vaccine but after the vaccine, her pain is more frequent). On an unknown date, the patient experienced PAIN IN EXTREMITY (pain in different areas of her body including her knee, ankles, shoulders, and arms), PAIN (pain has been going on for about three months now), the first episode of ARTHRALGIA (pain in different areas of her body including her knee, ankles, shoulders, and arms), the second episode of ARTHRALGIA (pain in different areas of her body including her knee, ankles, shoulders, and arms) and the third episode of ARTHRALGIA (pain in different areas of her body including her knee, ankles, shoulders, and arms). At the time of the report, PAIN IN EXTREMITY (pain in different areas of her body including her knee, ankles, shoulders, and arms), PAIN (history of pain in those area prior to the vaccine but after the vaccine, her pain is more frequent), PAIN (pain has been going on for about three months now) and the last episode of ARTHRALGIA (pain in different areas of her body including her knee, ankles, shoulders, and arms) outcome was unknown.            No treatment medication were provided by the reporter.
she hurts all over; fever of 101.8 Deg. F; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (she hurts all over), PYREXIA (fever of 101.8 Deg. F) and CHILLS (Chills) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Feb-2021, the patient experienced PAIN (she hurts all over), PYREXIA (fever of 101.8 Deg. F) and CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL) (oral) at an unspecified dose and frequency. At the time of the report, PAIN (she hurts all over), PYREXIA (fever of 101.8 Deg. F) and CHILLS (Chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Feb-2021, Body temperature: 101.8 (High) 101.8 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.
Patient received 2 doses of pfizer for primary series and received 1 dose of Johnson & Johnson vaccine. Vaccinator failed to check vams system if patient had received previous COVID-19 doses and patient checked "NO" on questionnaire for the following question: Have you ever received a COVID-19 vaccine.
resident was administered 0.5 ml of booster dose. No adverse reactions were noted. Resident monitored closely for symptoms or reactions . None have been noted.  Assessed by physician.
Information has been received from a pharmacist referring to 2 patients of unknown age and gender. Information about concurrent conditions, medical history and concomitant medication was not provided. On unknown dates the patients were vaccinated with improperly stored dose of ZOSTAVAX (lot#, dose, dose# and route unknown). No adverse effect reported. Additional information is not expected since there was no consent for follow up contact.
ADministered vaccines and within 5 min of administration pt. became very pale and proceeded to faint. When coming to she began to shake for 15 sec and then was alert. Applied oxygen to pt and had pt stay at clinic 45 min for observation.
pt recv vax 9FEB96 & devel an inj site rxn, characterized by arm pain & edema over half of arm & a wheal area of discoloration w/a dark red center;As of 12FEB96 the rxn was worsening;tx w/DPH & cool compresses;
Fever of 100.3, diarrhea and vomited once on 10/11, headache, chills,achy all over. On 10/12 lots of liquid diarrhea. Better on 10/13, but still some diarrhea. Stomach still hurt on 10/14.
This currently 65 year old female reports redness and swelling "that is more than just a little" on 09Nov2011 at the site of Pneumovax 23 administration. Pneumovax 23 was administered 08Nov2011 SC in right lower tricep. Patient was referred to MD for evaluation of reaction on 09Nov2011. Patient stated that she was heading immediatly to an urgent care center.
I thought I was suffering from a bad sinus infection, completed a ten day course of Augmentin about two and a half weeks ago. The infection didn't go away, seemed to get worse with worsening headache/eye pain/fatigue and nasal congestion/post nasal drip. I requested a nasal swab by my provider to identify what was going on in my nose.
Severe back pain.  Pt states he woke up after sleeping through daytime post injection (night shift worker).  Upon awakening, pain was severe in back. Pt was unable to report to work evening of 10/19. No reaction of site of injection.  No headache, neck stiffness, or fever. Pt said pain was continuing on 10/20 and was instructed to report to Occupational health department for evaluation of fitness for duty/return to work status. Pt to be re-checked on 10/22.
Pt. symptoms, flu like, achy, diarrhea, tried, no energy, fever, nausea, no appetite, malaise. for 3-5 days from each does  Second Dosage - given Nov. 4th Wed. 2:30 pm central
I began to feel very itchy all over my body within 30-60 minutes, I felt swollen in my hand, feet, tongue, my mouth and throat felt itchy, the itching got so bad that i had hives in some places such as my forearm and legs and skin just felt like it was on fire, I had issues breathing and felt as though someone was sitting on my chest, i have been shortness of breath since and have trouble catching my breath.. This was all that same night. The next day I had the same issues adding the sore arm of the injection site and feeling very tired all day. the next day from there am I am feeling better but am still experiencing shortness of breath, I am using my inhaler, I am still itchy but not as severe as the first night or next day. The arm tenderness has gone unless you touch the injection site and am no longer feeling over tired.
Development of chronic dermatitis affecting multiple body sites with associated lymphadenopathy, no associated fever.  She was treated with 2-3 months of oral prednisone and remains on long term therapy with topical steroids and may require a chronic systemic medication for dermatitis (Dupixent).  She does not have a prior history of dermatitis prior to vaccination.
After receiving Shingrix vaccine in left arm, two hours after,  my left arm became stiff and sore in an area from the vaccination site past the elbow became painful to the touch.   By the next morning the same area had broken out in a swollen rash  that was warmer to the touch than the surrounding skin and itched strongly.  Rash has continued for 4 days, but is starting to abate today.
Nausea, intestinal discomfort, lymphadenopathy in right axilla, severe headache
This spontaneous report as received from a medical assistant who administers vaccines, refers to two patients of unknown age and gender. Information regarding medical history was not provided. on 05-DEC-2012 the two patients were vaccinated with dose 2 of expired GARDASIL intramuscularly. Lot number was reported as 0766Z with expiry date of 15-OCT-2012. No adverse events were reported. The date the first dose was administered was unknown for each patient. No other co-suspects were reported. No concomitant medications were reported. No outcome was reported. Additional information has been requested.
Right arm pain, right neck pain, right axillary pain, right hand tingling, onset 1 day after vaccine administration. Seen at clinic 3 days after vaccine administration.
10 mins after 2nd dose, pt started having upper back itchy feeling.  Came to nurse observation area. no rash observed.  BP elevated.
severe chills and alternating sweating that evening, followed by severe pancreatic pain/headaches/body aches over the next 96 hours
Sweating; FEVER; Chills; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Sweating), PYREXIA (FEVER) and CHILLS (Chills) in a 47-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HYPERHIDROSIS (Sweating), PYREXIA (FEVER) and CHILLS (Chills). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, HYPERHIDROSIS (Sweating), PYREXIA (FEVER) and CHILLS (Chills) outcome was unknown.            The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was not applicable.  No relevant concomitant medications were reported.    This case was linked to MOD-2021-091846 (Patient Link).
No adverse effects were reported; Incorrect product storage; This spontaneous report was received from a medical assistant concerning a male patient of an unknown age. Information regarding the patient's concurrent conditions, medical history, drug reactions or allergies and concomitant medication was not reported.   On 20-MAY-2019, the patient was vaccinated with an improperly stored (product storage error) dose of Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (LIQUID PEDVAXHIB) batch # R012001, expiration date 06-NOV-2020, (strength, dose, frequency, route of administration and anatomical location, were not reported) for prophylaxis. No adverse effect were reported.   The vaccine was stored at temperature above of 47° fahrenheit (F) (48.7 F) for the time frame of 1 hour and 38 minutes. No previous temperature excursion was reported.  The call was because of data logger.; Sender's Comments:  US-009507513-1905USA011967: US-009507513-1905USA013166:
The arm is very sore for a long period of time. When she lifts her arm it hurts. She is in pain all the time. She had gotten the shot on 10/5/12. She has sharp shooting pain when she lifts her arm.
lost the ability to function as a 22 year old, work, walk, comprehend and losing daily/ can't pay his own bills, he can't live on his own at times can't even show or go to the bathroom without help; lost the ability to walk; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the parent.  A 22-year-old male patient received BNT162b2 (BNT162B2), as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 immunization (Dose 1, Manufacturer Unknown), for COVID-19 IMMUNIZATION. The following information was reported: LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (non-serious), outcome "unknown", described as "lost the ability to function as a 22 year old, work, walk, comprehend and losing daily/ can't pay his own bills, he can't live on his own at times can't even show or go to the bathroom without help"; GAIT INABILITY (non-serious), outcome "unknown", described as "lost the ability to walk".  Additional information: Reporter have a 24-year-old son who at 22, within 2 weeks of 2nd shot has lost the ability to function as a 22-year-old, work, walk, comprehend and losing daily, the want or will to stay and fight, He can't pay his own bills, he can't live on his own at times can't even show or go to the bathroom without help. Stop ignoring the facts and the evidence. How much longer until your company finds a cure for the Vaccine injured, or even acknowledges the damage that has been done, and starts working on fixing the damage. Fix the vaccine issue, and STOP worrying about the common cold (COVID) that we know have enough evidence of. Please help my son and all the Other people that are still suffering, We cant help the ones who have already passed, Sudden heart issues, you can help the one alive and suffering.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Less than 24 hours after injection, pt started having pain to site of injection. Pt then developed altered mental status and was admitted to the hospital. Pts arm 2 days later had large area of erythema, pain and warmth. The site has been monitored the past 2 days and the area of erythema continues to spread, pt now prescribed Clindamycin for 5 days. MD believes it is a rash/cellulitis.
I was woken up by fever, chills, body aches. Felt overall tiredness. I had these symptoms for about 24 hours. I took some Nyquil
Breakthrough case admission after 4 vaccines Pfizer 2/24/21 NO LOT#;  Pfizer 3/17/21 Lot# EN6207;  Pfizer 8/20/21 Lot# FC3277;  Pfizer 11/8/22 Lot# GJ3277;
20 days after vaccine I developed a hard lump that was red itchy and hot to the touch..
9 year old patient rec'd Fluzone High Dose, no treatment necessary, no adverse reaction.
Expired Shingrix administered; This case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a 84-year-old male patient who received Herpes zoster (Shingrix) (batch number 299BM, expiry date 10th October 2022) for prophylaxis.   On 2nd February 2023, the patient received the 1st dose of Shingrix. On 2nd February 2023, unknown after receiving Shingrix, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   Additional Information: GSK receipt date: 06-Feb-2023 Reporter's comment: The reporter consented to follow-up by email. Additional supportive information: The patient received an expired dose of Shingrix by error, which led to expired vaccine used.
Treatment of COVID-19; Treatment of COVID-19; Pfizer, Dose Number: 1, 2 / Moderna, Dose Number: 3, 4; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 43-year-old male patient received BNT162b2 (BNT162B2), on 06Apr2021 as dose 1, single (Lot number: EP7533), in left arm and on 27Apr2021 as dose 2, single (Lot number: EW0175) at the age of 41 years, in left arm for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 23Nov2021 as dose 3 (booster), single (Lot number: 018F21A), in left arm for covid-19 immunisation; davesomeran, elasomeran (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), on 11Nov2022 as dose 4 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Attention deficit hyperactivity disorder" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Bacitracin, reaction(s): "Allergic to bacitracin". The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 23Nov2021, outcome "not recovered", described as "Pfizer, Dose Number: 1, 2 / Moderna, Dose Number: 3, 4"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures (Paxlovid from 01Jul2023 to 06Jul2023) were taken as a result of drug ineffective, covid-19.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300247274 same reporter/patient, different product/AE;
Sore Left Arm; Left Arm joint ache; This is a spontaneous report from a contactable consumer. A 57-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EN6199), via an unspecified route of administration, administered in arm left on 13Mar2021 (at the age of 57-years-old) as dose 1, single for covid-19 immunisation. The patient was not pregnant at the time of vaccination. The vaccine was administered at the Pharmacy/Drugstore. The patient medical history included type 1 diabetes from an unknown date. Concomitant medications included levothyroxine sodium (LEVOXYL); insulin lispro (HUMALOG); and insulin glargine (LANTUS); all were taken for an unspecified indication, start and stop date were not reported. On 13Mar2021, the patient experienced sore left arm and left arm joint ache. The outcome of the events was recovered with no treatment received.   No follow-up attempts are possible. No further information is expected.